The population of India stands at an impressive 1.3 billion people, thus placing immense pressure on its public health services. The Indian government is working in tandem with public-private partnerships to tackle this issue through the creation of research and education centers.
In the past several years, India has transitioned into a new chapter in public health. The onset of the COVID-19 pandemic underlined the importance of upgrading the public health system.
Mumbai: Reduced hearing, dry mouth, throbbing headache and conjunctivitis are some of the newer symptoms increasingly seen in Covid-19 patients. Members of the state Covid-19 taskforce urged physicians to suspect Covid even in cases where the hallmark signs of cough, sore throat, shortness of breath are absent.
BEIJING: China on Monday reported an anthrax pneumonia patient from northern Hebei province’s Chengde city, who had contact history with cattle, sheep and products that come from these animals.
At the end of the 2019, a virus named Severe Acute Respiratory Syndrome Coronavirus (SARS- Cov-2) detected in Wuhan, China. Until November 2021, diagnosis of more than 247 million people and death of 5.01 million people patients due to Cov-2 virus.
Antimicrobial resistance is a growing problem in the medical field. More the bacteria are treated with antibiotics more are they becoming resistant to them. This resistance can cause serious problems for patients, as it can make infections more difficult to treat. In some cases, it can even lead to death.
Washington: People suffering from serious long-term symptoms of coronavirus disease, also known as Long Covid, may qualify as “disablility” under federal law, US President Joe Biden has said.
Biden on Monday released guidance on federal protections and resources to those suffering from lingering Covid symptoms, such as fatigue or brain fog, which “can sometimes rise to the level of a disability”, NBC news reported.
NEW DELHI: Of India’s population above the age of six, 67.6 percent have developed antibodies against Covid-19, found the Indian Council of Medical Research’s (ICMR) fourth national serosurvey done between June 14 and July 6, the Lok Sabha was informed on Friday.
New Delhi: As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week, sources said on Thursday.
According to sources, children in the above-mentioned age group have already received the first dose of the vaccine.
NEW DELHI: A total of 45,432 cases of mucormycosis have been reported by states and UTs till July 15 of which 21,085 affected people are receiving treatment and 4,252 have died, the Rajya Sabha was informed on Tuesday.
